Less Invasive Treatment Feasible for Early-Stage Rectal Cancer
TUESDAY, Dec. 15, 2020 -- Short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC) achieves a high level of organ preservation and improved quality of life, according to a study published online Dec. 10 in The Lancet Gastroenterology & Hepatology.
Simon P. Bach, M.B., B.S., M.D., from the Cancer Research U.K. Clinical Trials Unit in Birmingham, and colleagues conducted a randomized, open-label feasibility study involving participants with rectal adenocarcinoma, stage T2 or lower, with a maximum diameter of 30 mm or less. Participants were randomly assigned to undergo either organ preservation with short-course radiotherapy followed by transanal endoscopic microsurgery (27 patients) or total mesorectal excision (28 patients).
The researchers found no deaths within 30 days of initial treatment; one patient assigned to organ preservation died within six months following conversion to total mesorectal excision. Eight patients (30 percent) randomly assigned to organ preservation converted to total mesorectal excision. Serious adverse events occurred in 15 and 39 percent of patients randomly assigned to organ preservation and total mesorectal excision, respectively. A complete response to radiotherapy was achieved by 30 percent of patients assigned to organ preservation. Compared with patients randomly assigned to total mesorectal excision, those assigned to organ preservation showed improvements in patient-reported bowel toxicities and quality of life and function scores, which were sustained over 36 months.
"TREC provides evidence to support further evaluation of organ preservation strategies that incorporate short-course radiotherapy as an alternative to radical surgery for early-stage rectal cancer," the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Read this next
FRIDAY, Jan. 22, 2021 -- There was a significant decrease in the number of patients undergoing screening tests for cancer and in the number of resulting diagnoses of cancerous and...
THURSDAY, Jan. 21, 2021 -- Regular use of aspirin is associated with a reduced risk for colorectal cancer (CRC) among those with initiation of aspirin before age 70 years,...
TUESDAY, Jan. 19, 2021 -- Routine use of prophylactic postoperative antibiotics does not improve outcomes following endoscopic sinus surgery (ESS) for chronic rhinosinusitis,...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.